Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Reserpine (N1867): Practical Guidance for Lab Research Use

    2026-04-11

    Reserpine (N1867): Technical Application Guide for Researchers

    What This Product Solves

    Reserpine (3,20-Yohimban-16-carboxylic acid, CAS No. 50-55-5) is a high-purity, bioactive natural product extracted from Rauvolfia species, widely adopted in research focused on neurotransmitter depletion and antihypertensive mechanism studies. Its precise chemical identity—methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate—enables reproducible experimental modulation of monoaminergic systems. Researchers utilize Reserpine primarily to probe neuropharmacological pathways, validate protocols for central neurotransmitter depletion, and model antihypertensive responses. Its use is not appropriate for diagnostic or medical applications, nor for studies requiring aqueous or ethanol solubility.

    For additional context on Reserpine’s integration into experimental workflows, see Reserpine (N1867): Benchmarks in Neurotransmitter Depletion Research, which details its role as a neuropharmacology standard. Researchers seeking atomic-level workflow integration may consult Reserpine (N1867): Atomic Insights for Neurotransmitter Depletion.

    Protocol Parameters

    • Solubility assessment | ≥13 mg/mL in DMSO (with gentle warming) | All neuropharmacology and neurotransmitter depletion assays requiring stock solutions | Enables preparation of high-concentration stocks for dosing and serial dilution; critical due to compound's insolubility in water and ethanol | product_spec [Reserpine product page]
    • Storage temperature | -20℃ (solid, sealed, cool, dry) | Long-term compound stability and batch-to-batch consistency | Prevents degradation, preserves activity for extended periods between experiments | product_spec [Reserpine product page]
    • Solution stability | Use freshly prepared DMSO solutions; avoid long-term storage (>24 hours) | All assays dependent on consistent dosing or pharmacological effect | Limits risk of compound hydrolysis or loss of potency, supporting reproducible results | workflow_recommendation

    Workflow Setup and QC Checklist

    • Compound reception and storage: Upon arrival (typically shipped on blue ice), inspect for physical integrity. Store immediately at -20℃ in a sealed, dry vial to limit moisture and oxidative degradation. [product_spec]
    • Solubility protocol: Dissolve Reserpine in DMSO at concentrations up to 13 mg/mL. Apply gentle warming (<40℃) if necessary; do not use water or ethanol as solvents due to insolubility. Vortex to ensure homogenous mixing. [product_spec]
    • Stock solution management: Prepare only the amount of solution required for immediate use; avoid freeze-thaw cycles and discard unused solutions after 24 hours. Label vials with preparation date and concentration. [workflow_recommendation]
    • Purity verification (optional): For critical assays, confirm purity via HPLC or NMR if instrumentation is available. APExBIO provides Reserpine at >98.8% purity, minimizing the need for further purification in most workflows. [product_spec]
    • Documentation and traceability: Record product lot, preparation method, and QC steps in lab notebooks or LIMS for reproducibility and audit trails. [workflow_recommendation]

    Common Failure Modes and Fixes

    • Precipitation in solution: If visible precipitation occurs, verify DMSO concentration and apply gentle warming. Do not attempt to dissolve in water or ethanol. If precipitation persists, reduce concentration or prepare a fresh aliquot. [workflow_recommendation]
    • Loss of potency: Avoid storing DMSO solutions for extended periods; always prepare fresh working solutions, as long-term storage can lead to hydrolysis and diminished activity. [product_spec, workflow_recommendation]
    • Batch-to-batch variability: Consistently source Reserpine from suppliers that provide full analytical data (e.g., HPLC, NMR) and maintain strict storage conditions. Record lot numbers for all experiments. [product_spec]
    • Compound degradation: Minimize exposure to light, ambient temperature, and moisture. Use amber vials when possible, and store under inert gas if long-term sample stability is required. [workflow_recommendation]

    Scope and Limitations

    Reserpine is validated for scientific research use in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. Its utility is bounded by its solubility profile—use only DMSO as a solvent—and its instability in solution over time. The compound is not suitable for diagnostic, medical, or clinical applications. There is no evidence supporting its use in aqueous, ethanol-based, or in vivo diagnostic workflows. When using Reserpine in protocol development, all solution manipulations should be performed under rigorously controlled conditions to maintain reproducibility and compound integrity. Researchers should be aware that equine or veterinary applications are not supported by the provided product dossier and remain outside the recommended scope.

    Conclusion

    Reserpine (SKU N1867) from APExBIO offers a high-purity, reproducible resource for controlled neurotransmitter depletion and antihypertensive mechanism studies. Its solid-state stability, DMSO solubility, and batch-verified purity support robust experimental workflows in neuropharmacology research. For detailed handling, always reference the Reserpine product page and adhere to best practices for solution preparation and storage. Limiting usage to research-only applications, and maintaining strict QC, ensures experimental reliability and compliance with institutional guidelines.